Company
Bicycle Therapeutics
- Biotech
- Location:
- Cambridge, United Kingdom
Description
Bicycle Therapeutics develops precision-guided Bicycle® molecules to penetrate deep tissues and target solid tumor cancers, collaborating with pharma and academic partners to explore applications that benefit patients with oncology and other unmet medical needs.
Bicycle Therapeutics is located in the Cambridge ecosystem.
Related
Artios PharmaArtios Pharma develops and advances DNA damage response targeted oncology medicines, including oral ATR and Polθ inhibitors and a DDRi-ADC…
OncomatryxOncomatryx targets the tumor microenvironment with stroma-focused antibody-drug conjugates, applying this approach to metastatic solid…
ThelperThelper develops antiviral antibody–drug conjugates that target a virally encoded biomarker abundantly expressed in aggressive, metastatic…
NETRIS PharmaNETRIS Pharma develops therapeutics that target Netrin-1 to overcome resistance to oncology treatments, producing monoclonal antibodies…
Captor TherapeuticsCaptor Therapeutics develops therapeutics using targeted protein degradation (TPD) to address high‑unmet‑need diseases such as cancer and…
CytovationCytovation develops CyPep-1, a tumor membrane-targeted immunotherapy, using peptide engineering to activate immune recognition and tumor…
STORM TherapeuticsSTORM Therapeutics develops small molecule inhibitors of RNA-modifying enzymes, including STC-15, a METTL3 inhibitor in clinical…
EDX MedicalEDX Medical develops diagnostic tests and point-of-care devices that combine molecular biology and digital technologies to provide…
EndomagEndomag provides surgical guidance products for breast cancer procedures, including lesion localization and sentinel node biopsy, to help…